Hytrin 5mg tablets

Država: Velika Britanija

Jezik: engleski

Izvor: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktivni sastojci:

Terazosin hydrochloride

Dostupno od:

Advanz Pharma

ATC koda:

G04CA03

INN (International ime):

Terazosin hydrochloride

Doziranje:

5mg

Farmaceutski oblik:

Oral tablet

Administracija rute:

Oral

Razred:

No Controlled Drug Status

Tip recepta:

Valid as a prescribable product

Proizvod sažetak:

BNF: 02050400; GTIN: 5060064170755

Uputa o lijeku

READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR
YOU.
•
Please keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or
pharmacist.
•
This medicine has been prescribed for you ONLY. Do not pass
it on to others. It may harm them, even if their symptoms are
the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist.
This includes any possible side effects not listed in this leaflet.
See section 4.
WHAT IS IN THIS LEAFLET:
1. What Hytrin Tablets are and what they are used for
2. What you need to know before you take Hytrin
Tablets
3. How to use Hytrin Tablets
4. Possible Side Effects
5. How to Store Hytrin Tablets
6. Contents of the pack and other information
1. WHAT HYTRIN TABLETS ARE AND WHAT THEY ARE
USED FOR
The name of your medicine is Hytrin 1 mg, 2 mg, 5 mg, or 10mg
Tablets (called Hytrin Tablets in this leaflet). Hytrin Tablets
contains the active ingredient terazosin. Terazosin belongs to a
group of medicines called alpha-blockers. Hytrin Tablets are used
in adults to treat high blood pressure. Hytrin Tablets are also
used in adults for the treatment of a condition called benign
prostatic hyperplasia (BPH) which affects the prostate and is
common in older men. This condition stops the flow of urine from
the bladder and can lead to symptoms such as a weak or
interrupted urine flow, a need to pass water more frequently
and/or a sudden need to pass water. Hytrin Tablets can relax the
muscle of the prostate gland and bladder exit to help relieve
these symptoms.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE HYTRIN
TABLETS
DO NOT TAKE HYTRIN TABLETS IF YOU:
•
are allergic to terazosin, or any of the following drugs:
alfuzosin, indoramin, prazosin, tamsulosin, doxazosin, or to
any of the other ingredients contained in this medicine listed
in section 6 (allergic reactions include mild symptoms such as
itching and/or rash. More severe symptoms include swelling
of the fa

Svojstava lijeka

OBJECT 1
HYTRIN TABLETS 5MG
Summary of Product Characteristics Updated 11-Oct-2018 | ADVANZ Pharma
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Hytrin 5 mg Tablets
Terazosin 5 mg Tablets
2. Qualitative and quantitative composition
Each tablet contains 5 mg of terazosin as monohydrochloride dihydrate.
Excipients with known effect:
Lactose: (123.07 mg)
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Tan, round, flat bevelled tablets embossed with logo and triangular
facets on one face and plain on the
other.
4. Clinical particulars
4.1 Therapeutic indications
Orally administered Hytrin is indicated in adults for the treatment of
mild to moderate hypertension. It
may be used in combination with thiazide diuretics and/or other
antihypertensive drugs or as sole therapy
where other agents are inappropriate or ineffective. The hypotensive
effect is most pronounced on the
diastolic pressure. Although the exact mechanism of the hypotensive
action of tera